Pro Health Tips
Friday, 28 September 2018
Durvalumab May Improve Survival of Non-small Cell Lung Cancer Patients
Non-small cell lung cancer patients have improved survival rate with durvalumab along with platinum-based chemoradiotherapy.
from Medindia Health News https://ift.tt/2NK7Csa
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment